Dr Reddy’s Laboratories, an integrated global pharmaceutical company, has launched atorvastatin calcium tablets 10 mg, 20 mg, 40 mg and 80 mg, a bioequivalent generic version of Lipitor (atorvastatin calcium) tablets in the US market on July 17, 2012 following the approval by the United States Food & Drug Administration (FDA) of Dr Reddy’s ANDA for atorvastatin calcium tablets.

The Lipitor brand had US sales of approximately $8.07 billion for the most recent twelve months ending March 2012 according to IMS Health.

Dr Reddy’s atorvastatin calcium tablets in 10 mg, 20 mg, 40 mg and 80 mg are available in bottle count sizes of 90 and 500.

Dr Reddy’s Laboratories Ltd. is committed to providing affordable and innovative medicines for healthier lives. It offers a portfolio of products and services including APIs, custom pharmaceutical services, generics, biosimilars, differentiated formulations and NCEs.